Exact Mass: 636.3383644
Exact Mass Matches: 636.3383644
Found 301 metabolites which its exact mass value is equals to given mass value 636.3383644,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Madlongiside C
Madlongiside C is found in fruits. Madlongiside C is a constituent of the famine food Madhuca longifolia. Constituent of the famine food Madhuca longifolia. Madlongiside C is found in fruits.
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
C39H48N4O4 (636.3675367999999)
PA(8:0/PGF1alpha)
C31H57O11P (636.3638301999999)
PA(8:0/PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGF1alpha), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGF1alpha/8:0)
C31H57O11P (636.3638301999999)
PA(PGF1alpha/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF1alpha/8:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
[5-hydroxy-2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(2-methylpropanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4-(2-methylpropanoyloxy)oxan-3-yl] decanoate
Withanoside XI
12beta-hydroxycimigenol 3-O-alpha-L-arabinopyranoside
3-O-alpha-L-arabinopyranosyl-20(S)-19alpha,23,24-trihydroxyursolic acid|brevicuspisaponin 2
1-Acetoxy-8,9-dibenzoyloxy-2-(2-methylbutanoyloxy)-6-hydroxydihydro-alpha-agarofuran
3-O-(4-hydroxy-3-methoxybenzoyl)ceanothic acid|3-O-vanillylceanothic acid
3,4-Di-O-isobutyryl-6-O-caprylsucrose|6-O-capryl-3,4-di-O-isobutyrylsucrose|6-O-Decanoyl-3,4-di-O-isobutyrylsucrose
alpha-L-arabinopyranosyl 3beta,23,27,29-tetrahydroxyolean-12-en-28-oate
24,25-epoxy-7-acetoxy-11-tigloloxy-7alpha,11alpha-dihydroxy-14,18-cycloapotirucalla-1,20(22)-dien-3,4:20,23-diolide|simaroubin B
21-hydroxycimigenol-3-O-beta-D-xylopyranoside|cimiracemoside B
2beta,3beta,6beta,28-tetrahydroxyolean-12-en-23-oic acid 23-O-alpha-L-arabinopyranosyl ester|gamboukokoenside A
5alpha-4,5-dihydro-16beta-hydroxy-scillirosidin-3-O-alpha-L-thevetoside
premyrsinol-3-propanoate-5-isobutyrate-7,13,17-triacetate
Weinbersterol disulfate A|Weinbetsterol disulfate A
3-O-(6-Deoxy-3-O-methyl-alpha-L-glucopyranoside),6-Ac-3,6,8,12,14-Pentahydroxybufa-20,22-dienolide|5alpha-4,5-dihydro-12beta-hydroxy-scillirosidin-3-O-alpha-L-thevetoside
(3beta,17R,23R,24S)-15,16-seco-14-formyl-16-oxo-16,23-epoxy-9,19-cycloart-3-O-beta-D-xylopyranoside|15,16-seco-cimiterpene B
2beta,3beta,23,24-tetrahydroxy-28-nor-olean-12-en-16-one-3-O-beta-D-glucopyranoside|platycodonoid B
2-{[5,7-dihydroxy-2-methyl-2-(4-methyl-3-pentenyl)-8-butanoyl-6-chromenyl]-methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-butanoyl-2,5-cyclohexadien-1-one|crassipin B
(1alpha,3beta)-1,25-dihydroxy-24-oxo-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-28-oic acid|(1alpha,3beta)-1,3,25-trihydroxy-24-oxocycloartan-28-oic acid 3-(beta-D-xylopyranoside)|nerviside G
3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,9(11),24(28)Z-triene-6beta,16beta,26,29-tetrol
1alpha-hydroxycimigenol 3-O-alpha-L-arabinopyranoside
20-ethyl-7-hydroxy-1alpha,14alpha,16beta,-trimethoxy-6-oxo-17(7->8)abeoaconitan-4ylmethyl 2-(2,5-dioxopyrrolidin-1-yl)benzoate|septonine
1alpha,3beta,5alpha-trihydroxy-6alpha,7alpha-epoxy-22R-with-24-enolide 3-O-beta-D-glucopyranoside|withanoside I
1alpha,3beta,19alpha,23,tetrahydroxyurs-12-en-28-oic acid-28-O-beta-D-xylopyranoside
12beta-hydroxycimigenol-3-O-alpha-L-arabinopyranoside
2-acetyl-3-(2-methylbutanoyl)-3,4-di(3-methylbutanoyl)sucrose
3,7,13,17-O-Tetraacetyl-5-O-(2-methylbutyryl)-14-oxopremyrsinol
Glu Phe Arg Trp
C31H40N8O7 (636.3019810000001)
Glu Phe Trp Arg
C31H40N8O7 (636.3019810000001)
Glu Arg Phe Trp
C31H40N8O7 (636.3019810000001)
Glu Arg Trp Phe
C31H40N8O7 (636.3019810000001)
Glu Trp Phe Arg
C31H40N8O7 (636.3019810000001)
Glu Trp Arg Phe
C31H40N8O7 (636.3019810000001)
Phe Glu Arg Trp
C31H40N8O7 (636.3019810000001)
Phe Glu Trp Arg
C31H40N8O7 (636.3019810000001)
Phe Arg Glu Trp
C31H40N8O7 (636.3019810000001)
Phe Arg Trp Glu
C31H40N8O7 (636.3019810000001)
Phe Val Trp Trp
Phe Trp Glu Arg
C31H40N8O7 (636.3019810000001)
Phe Trp Arg Glu
C31H40N8O7 (636.3019810000001)
Phe Trp Val Trp
Phe Trp Trp Val
Ile Arg Trp Tyr
Ile Arg Tyr Trp
Ile Trp Arg Tyr
Ile Trp Tyr Arg
Ile Tyr Arg Trp
Ile Tyr Trp Arg
Leu Arg Trp Tyr
Leu Arg Tyr Trp
Leu Trp Arg Tyr
Leu Trp Tyr Arg
Leu Tyr Arg Trp
Leu Tyr Trp Arg
Arg Glu Phe Trp
C31H40N8O7 (636.3019810000001)
Arg Glu Trp Phe
C31H40N8O7 (636.3019810000001)
Arg Phe Glu Trp
C31H40N8O7 (636.3019810000001)
Arg Phe Trp Glu
C31H40N8O7 (636.3019810000001)
Arg Ile Trp Tyr
Arg Ile Tyr Trp
Arg Leu Trp Tyr
Arg Leu Tyr Trp
Arg Trp Glu Phe
C31H40N8O7 (636.3019810000001)
Arg Trp Phe Glu
C31H40N8O7 (636.3019810000001)
Arg Trp Ile Tyr
Arg Trp Leu Tyr
Arg Trp Tyr Ile
Arg Trp Tyr Leu
Arg Tyr Ile Trp
Arg Tyr Leu Trp
Arg Tyr Trp Ile
Arg Tyr Trp Leu
Val Phe Trp Trp
Val Trp Phe Trp
Val Trp Trp Phe
Trp Glu Phe Arg
C31H40N8O7 (636.3019810000001)
Trp Glu Arg Phe
C31H40N8O7 (636.3019810000001)
Trp Phe Glu Arg
C31H40N8O7 (636.3019810000001)
Trp Phe Arg Glu
C31H40N8O7 (636.3019810000001)
Trp Phe Val Trp
Trp Phe Trp Val
Trp Ile Arg Tyr
Trp Ile Tyr Arg
Trp Leu Arg Tyr
Trp Leu Tyr Arg
Trp Arg Glu Phe
C31H40N8O7 (636.3019810000001)
Trp Arg Phe Glu
C31H40N8O7 (636.3019810000001)
Trp Arg Ile Tyr
Trp Arg Leu Tyr
Trp Arg Tyr Ile
Trp Arg Tyr Leu
Trp Val Phe Trp
Trp Val Trp Phe
Trp Trp Phe Val
Trp Trp Val Phe
Trp Tyr Ile Arg
Trp Tyr Leu Arg
Trp Tyr Arg Ile
Trp Tyr Arg Leu
Tyr Ile Arg Trp
Tyr Ile Trp Arg
Tyr Leu Arg Trp
Tyr Leu Trp Arg
Tyr Arg Ile Trp
Tyr Arg Leu Trp
Tyr Arg Trp Ile
Tyr Arg Trp Leu
Tyr Trp Ile Arg
Tyr Trp Leu Arg
Tyr Trp Arg Ile
Tyr Trp Arg Leu
Madlongiside C
PHDdiA-PA
C31H57O11P (636.3638301999999)
Cimimanol B
Mantuoluoside D
Mantuoluoside E
Mantuoluoside F
Vecuronium bromide
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Vecuronium (ORG NC 45) bromide is a non-depolarizing neuromuscular blocking agent that also acts as a nicotinic acetylcholine receptor (nAChR) inhibitor, a muscle relaxant, and can be used for pre-surgical anesthesia[1][2].
4-[[(4S,6R)-4,6-Bis[[(tert-butyl)dimethylsilyl]oxy]-1,3,4,5,6,7-hexahydro-2,2-dioxidobenzo[c]thien-1-yl]methylene]octahydro-a,7a-dimethyl-1H-indene-1-acetaldehyde
HPPH
C39H48N4O4 (636.3675367999999)
C1420 - Photosensitizing Agent
Withalongolide J
A withanolide saponin that consists of 22,26-epoxyergosta-5,24-dien-28-ol substituted by additional hydroxy groups at positions 1, 3 and 19, an oxo group at position 26 and a beta-D-glucopyranosyl residue at position 28 via a glycosidic linkage. It has been isolated from the aerial parts of Physalis longifolia.
[6-[4-Acetyloxy-3-hydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-4,5-di(pentanoyloxy)oxan-3-yl] pentanoate
[5-Hydroxy-2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(2-methylpropanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4-(2-methylpropanoyloxy)oxan-3-yl] decanoate
(2E,4E,6E,11R)-12-[(4S,4aR,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-11-hydroxydodeca-2,4,6-trienoate
C33H50NO11- (636.3383690000001)
Sucrose-2-(2-methyl)butyryl-4-(2-methyl)butyryl-3-(6-methyl)heptanoate
2-[[(2R)-3-acetyloxy-2-[(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
2-[[(2R)-2-acetyloxy-3-[(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
2-[[(2R)-3-acetyloxy-2-[7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
2-[[(2R)-2-acetyloxy-3-[7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
2-[[(2R)-3-acetyloxy-2-[7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
2-[[(2R)-2-acetyloxy-3-[7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C30H55NO11P+ (636.3512549999999)
3-O-vanillyceanothic acid
A natural product found in Ziziphus cambodianus.
Joro spider toxin-4
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms A natural product found in Nephila clavata.
(132S, 17S, 18S)-132-hydroxy-20-chloro-ethylpheophorbide a
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(4,4,4-trifluoro-1-oxobutyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
C32H43F3N4O6 (636.3134534000001)
N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[(4,4,4-trifluoro-1-oxobutyl)amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
C32H43F3N4O6 (636.3134534000001)
1-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(1-methyl-4-imidazolyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea
2-[[(2R)-2-(4-carboxybutanoyloxy)-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[O-[1-O-Palmitoyl-2-O-(4-hydroxy-7-oxo-5-heptenoyl)-L-glycero-3-phospho]choline]anion
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
2-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (4E,7E)-hexadeca-4,7-dienoate
[1-[(E)-dec-4-enoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate
[1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
phosphatidylserine 25:0(1-)
A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups contain a total of 25 carbons and are fully saturated.